Morgan Stanley may invest up to $186 mln in India office development: sources
MUMBAI (Reuters) - The global real estate fund of Morgan Stanley (MS.N) is in talks with the Wadhwa Group to invest 9 billion to 10 billion rupees in an office development in Mumbai, three sources familiar with the matter told Reuters.
Morgan Stanley Real Estate Investing (MSREI) plans to invest in jointly developing 1.6 million square feet of office space in Bandra Kurla Complex, a financial district in Mumbai, said two of the sources on condition of anonymity as the deal is not yet final.
Mumbai-based Wadhwa Group has already begun construction on the project, ONE BKC, which will consist of two office towers and is due to be completed by 2014.
If the deal is concluded it would be the first investment by MSREI in an office development in India, said one source.
MSREI has invested about $850 million in Indian real estate, mainly in residential projects, including $100 million to $125 million in a housing project by Mumbai-based Sheth Developers, Reuters reported in December 2011.
MSREI and the Wadhwa Group declined to comment.
Private equity investors have been cautious about the Indian real estate market, investing $1.95 billion in 2012 compared with $9.8 billion in 2007, according to data from research firm Venture Intelligence.
On Thursday, Reuters reported that U.S. private-equity firm Blackstone Group, along with two other companies, agreed to buy a business park in Bangalore for $367 million, citing two sources with direct knowledge of the matter.
(Editing by Tony Munroe)
- Tweet this
- Share this
- Digg this
- Pakistani family sentenced to death over "honour killing" outside court
- Alumnus dead after opening fire at Florida State University, wounding 3 |
- Mike Nichols, award-winning American director, dies at 83
- UPDATE 2-Doctor who treated source of second Mali Ebola outbreak dies
- Mike Nichols, award-winning American director, dies at 83 |
Kotak Mahindra Bank has agreed to buy ING Vysya in an all-share deal valuing its smaller rival at $2.4 billion, bulking up as analysts predict the start of long-awaited consolidation in a crowded banking sector. Full Article
U.S. court overturns bid by Ranbaxy to block launch of rival generic drugs. Full Article
Tech Mahindra to buy U.S.-based network services operator for $240 million Full Article
Infosys unit's overbilling Apple led to exit of top execs - sources. Full Article